Vivek Ramaswamy’s artful narrative, meticulously tailored for the GOP primary voter, weaves a tale of principled sacrifice and success. According to his version, he helmed the leadership of Roivant, a multi-billion-dollar American pharmaceutical company he founded, and gallantly relinquished his CEO role in 2021 due to his unwavering stance against ESG principles, despite facing opposition from his liberal workforce. While this narrative might seem appealing, it is akin to the endless “flip-flops” that have plagued his campaign—an elaborate work of fiction that unravels upon a modicum of scrutiny.
SEARCH OUR SITE
HOW TO READ
Click on the titles to reveal the full article, the original link, and to reveal the social sharing icons.
RECENT POSTS
- The U.S. Will Very Likely Fight a 3-Front War Against Russia, China, and Iran, Palantir’s Alex Karp Says
- Milford Honor Student’s Detainment “Humiliating”
- Canadians Don’t Want Trump in Canada
- Former Doge Engineer Says Federal Waste and Fraud Were ‘Relatively Nonexistent’
- Tourists Being Grabbed Off the Street
- White House Struggles to Find Qualified People Willing to Work for Pete Hegseth
- Trump’s Dementia
- Newsom Cites Trump’s Criminality
- Speaker Johnson’s Hypocrisy
- Walking Into Walls and Tripping Up Stairs
- Trump Appoints 22-Year-Old Ex-Gardener and Grocery Store Assistant to Lead U.S. Terror Prevention
- Deport Illegals Yes, But Legal Workers, NO
- Former Federal Inmate Pardoned by Trump Tapped as Bureau of Prisons Deputy Director
- End Presidential Revenge
- The J5 Pipe Bomber is NOT Marjorie Taylor-Greene
- He’s Anti-Democracy and Pro-Trump: The Obscure ‘Dark Enlightenment’ Blogger Influencing the Next US Administration
- Trump Taps Palantir to Compile Data on Americans
- Gabbard Wants Fox Hosts to Feed Trump Intel: ‘Doesn’t Read’
- On the Campaign Trail, Elon Musk Juggled Drugs and Family Drama
- How Trump Violates the Emoluments Clause